Wednesday, February 28, 2018 10:15 PM ET
Insider Makes Significant Stock buy in Abbott Laboratories (ABT) Shares Breaks Selling Trend of Last 90 Days
There was significant buying activity in Abbott Laboratories shares by an insider today, as revealed in a form 4 document filed with the SEC. One insider — Daniel J Starks, Director — purchased 40,037 shares in the company having a market value of approximately $2,429,237. There have been 4 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the selling of 236,486 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 196,449 shares and have averaged 55,305 shares per transaction over this time period.
The number of insider buy/sell trades at Abbott Laboratories is greater than that of the 121 peer company average over the last 90-day period. The Pharmaceuticals peer group saw 70 buy/sell trades during this period for an average of 0.6 transactions per company. However, the number of shares traded per transaction by Abbott Laboratories insiders is lower than its peers. Within the peer group there were 2,093,442 shares purchased and 3,954,009 shares sold with company insiders selling 26,580 shares on average over this time period.
The data obtained in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2018 UpTick Data Technologies. All rights reserved.